SSB and synovial sarcoma: The HCV-driven autoimmune response in patients with SS-HCV is characterized by a lower frequency of autoantibodies against Ro and La human ribonucleoproteins, an abnormal predominant presence of anti-La among anti-Ro antibodies, and a higher frequency of cryoglobulinemic-related immunological markers (including positive RF) in comparison with SS patients without HCV.